Synexus continues to expand across Eastern Europe with three new Dedicated Research Centres in Bulgaria, Poland and Romania, bringing the total to nine centers in Eastern Europe and a total network of 25 across Europe and Africa. These new centers will provide the company’s clients in pharma and CROs with an expanding pool of patients.

Synexus, which is based in the UK, is the world’s largest multi-national company entirely focused on the recruitment and running of clinical trials at its own 25 dedicated research centers and 24 affiliated sites.

“This is our ninth Dedicated Research Centre in Eastern Europe, which will help us to provide much greater support to the global pharmaceutical industry,” said Christophe Berthoux, chief executive officer, Synexus. “Since we opened our first center in Poland in 2006 we have had an ongoing program of investment in the region. Throughout the world we are upgrading our centers to provide the very latest facilities for our patients and to provide our clients in pharma with the most accurate data.”

The new Polish facility is Synexus’ largest research center in the world. It occupies 1,000 square meters at Beniowskiego Street, in Gdansk.

Romania’s new 820 square meter center is based in the capital, Bucharest, which has a population of two million. Romania has been part of Synexus’ development plans since early 2000, as the country’s total population is over 20 million and the number of new clinical trials which has been granted approval during the last five years is at least 200.

A total area of 650 square meters for the Dedicated Research Centre in Bulgaria is situated in Sofia with eight medical rooms, two administration rooms, monitoring and meeting rooms and other areas.